Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. SOC Telemed's annualized net income for the quarter that ended in Dec. 2021 was $-50.54 Mil. SOC Telemed's average Total Stockholders Equity over the quarter that ended in Dec. 2021 was $111.10 Mil. Therefore, SOC Telemed's annualized ROE % for the quarter that ended in Dec. 2021 was -45.49%.
The historical rank and industry rank for SOC Telemed's ROE % or its related term are showing as below:
TLMDW'
s ROE % Range Over the Past 10 Years
Min: -585.23 Med: -315.36 Max: -45.49
Current: -45.49
During the past 3 years, SOC Telemed's highest ROE % was -45.49%. The lowest was -585.23%. And the median was -315.36%.
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is one times the annual (Dec. 2021) net income data. The Revenue data used here is one times the annual (Dec. 2021) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
SOC Telemed ROE % Related Terms
SOC Telemed ROE % Historical Data
* Premium members only.
The historical data trend for SOC Telemed's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SOC Telemed ROE % Chart
SOC Telemed Annual Data
Trend
Dec19
Dec20
Dec21
ROE %
0.00
-585.23
-45.49
SOC Telemed Semi-Annual Data
Dec19
Dec20
Dec21
ROE %
0.00
-585.23
-45.49
TLMDW vs PHCI, JYNT, TALK: ROE % Comparison
For the Medical Care Facilities subindustry, SOC Telemed's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SOC Telemed ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SOC Telemed's ROE % distribution charts can be found below:
* The bar in red indicates where SOC Telemed's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is one times the annual (Dec. 2021) net income data.
ROE % is displayed in the 30-year financial page.
SOC Telemed (TLMDW) has a ROE % of -45.49% as of Dec. 2021. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on SOC Telemed and its competitors.
Is SOC Telemed's ROE % too high?
SOC Telemed's current ROE % is -45.49%. Overall, SOC Telemed has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does SOC Telemed's ROE % compare to PHCI and JYNT?
SOC Telemed's ROE % of -45.49% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROE % is 6.11. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 6.11, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on SOC Telemed and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 6.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SOC Telemed's current ROE % is -45.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SOC Telemed stock overvalued right now?
SOC Telemed (TLMDW) has a current ROE % of -45.49%. The current ROE % is -45.49%. SOC Telemed's overall GF Score™ is 19/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For SOC Telemed (TLMDW), the current ROE % is -45.49% as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
SOC Telemed Inc is a provider of acute care telemedicine services and technology to U.S. hospitals and healthcare systems based on number of clients. It provides technology enabled clinical solutions which include acute teleNeurology, telePsychiatry, and teleICU, and telePulmonology service. It supports specialty care, providing time-sensitive specialty care when patients are vulnerable and may not otherwise have access. Its solution was developed to support complex workflows in the acute care setting by integrating cloud-based software platform, Telemed IQ, with a panel of patient advocates and a network of clinical specialists to create a seamless, acute telemedicine solution.
19GF Score
Get the complete analysis for TLMDW
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TLMDW has been successfully added to your 
